Figure 3. . Hemolytic activity and cytotoxicity of OZE-I, -II and OZE-III.
(A) Human erythrocytes were treated with serial dilutions of Triton X-100 (0.002–001%) or compounds (0.125–164 μg/ml). (B) Cytotoxicity of compounds was evaluated using HepG2 cells. The viability of HepG2 cells was measured after treatment with serially diluted concentrations (0.125–164 μg/ml) of each compound.